Shire Pharmaceuticals Acquires Advanced Biohealing for $750,000,000

  • Feed Type
  • Date
    5/17/2011
  • Company Name
    Advanced Biohealing
  • Mailing Address
    36 Church Ln. Westport, CT 06880
  • Company Description
    Advanced BioHealing (ABH) is a specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products for wound care. We are a privately held company with two approved products: Dermagraft and TransCyte. Our development pipeline also includes a next-generation bioengineered wound therapy for which two Investigational Device Exemption (IDE) applications have been conditionally approved by the FDA.
  • Website
    http://abh.com
  • Transaction Type
    M&A
  • Transaction Amount
    $750,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The transaction will be paid for with all cash.